Meng (100) and Zhu (101) found that administration of recombinant human IL-37 protein, either via intranasal inhalation or intravenous injection, effectively reduced levels of IL-4, IL-5, IL-6, and IL-13 in a chronic HDM-induced asthma model. Here, IL37 is linked to asthma.